Document is current
Any future updates will be listed below
-
Authors
Burtscher, Mira L https://orcid.org/0000-0003-2628-0795
Gade, Stephan
Garrido-Rodriguez, Martin https://orcid.org/0000-0003-4125-5643
Rutkowska, Anna
Werner, Thilo
Eberl, H Christian
Petretich, Massimo https://orcid.org/0009-0006-2032-3239
Knopf, Natascha
Zirngibl, Katharina
Grandi, Paola https://orcid.org/0000-0002-6337-1269
Bergamini, Giovanna
Bantscheff, Marcus https://orcid.org/0000-0002-8343-8977
Fälth-Savitski, Maria https://orcid.org/0000-0002-4923-3214
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
-
Funding
Funding for this research was provided by:
GlaxoSmithKline
Pfizer
Sanofi
Travere Therapeutics
Stadapharm
Astex Pharmaceuticals
Grunenthal
- License Information
-
More Information
Article History
Received: 17 January 2024
Revised: 13 February 2024
Accepted: 20 February 2024
First Online: 7 March 2024
Disclosure and competing interest statement
: Saez-Rodriguez J reports funding from GSK, Pfizer, and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer, and Grunenthal. Garrido-Rodriguez M was supported through state funds approved by the State Parliament of Baden-Württemberg for the Innovation Campus Health + Life Science Alliance Heidelberg Mannheim. Gade S, Rutkowska A., Werner, T., Eberl H.C., Petretich M., Knopf N., Zirngibl K., Grandi, P., Bergamini G., Bantscheff M. are employees of and holds/stocks shares in GSK. Fälth-Savitski M. holds stocks in GSK. JSR is a member of the Advisory Editorial Board of Molecular Systems Biology. This has no bearing on the editorial consideration of this article for publication.
